Literature DB >> 11929695

A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate.

Jong Hwa Yum1, Dongeun Yong, Kyungwon Lee, Hyon-Suk Kim, Yunsop Chong.   

Abstract

Serratia marcescens is an important nosocomial pathogen which is often resistant to multiple antimicrobial agents. An imipenem-resistant S. marcescens isolate from a urine specimen was found to carry a bla(VIM-2) gene cassette on a class 1 integron. This finding indicates that bla(VIM-2) is presently spreading even to Serratia spp. in Korea, which could compromise the usefulness of carbapenem in the treatment of multi-resistant Gram-negative bacilli infections. Clinical laboratory should be able to detect the VIM-2-producing isolates with even low carbapenem MIC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929695     DOI: 10.1016/s0732-8893(01)00352-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  18 in total

1.  VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals.

Authors:  P Giakkoupi; A Xanthaki; M Kanelopoulou; A Vlahaki; V Miriagou; S Kontou; E Papafraggas; H Malamou-Lada; L S Tzouvelekis; N J Legakis; A C Vatopoulos
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.

Authors:  Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Rodrigo E Mendes; Mariana Castanheira; Patricia Garcia; Manuel Guzman; Mark A Toleman; Timothy R Walsh; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

4.  Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Authors:  Mei-Fen Tsou; Wen-Liang Yu; Siu Wan Hung; Chizh-Ju Chi; Ssu Ching Chen; Lii-Tzu Wu
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.

Authors:  P Giakkoupi; L S Tzouvelekis; G L Daikos; V Miriagou; G Petrikkos; N J Legakis; A C Vatopoulos
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  First isolation of blaVIM-2 in an environmental isolate of Pseudomonas pseudoalcaligenes.

Authors:  Sandra Quinteira; Helena Ferreira; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

7.  Class I integron with a group II intron detected in an Escherichia coli strain from a free-range reindeer.

Authors:  Marianne Sunde
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

8.  Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.

Authors:  Borum Suh; Il Kwon Bae; Juwon Kim; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

Review 9.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

10.  Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.

Authors:  Kyungwon Lee; Sook-Jin Jang; Hee-Joo Lee; Namhee Ryoo; Myungshin Kim; Seong-Geun Hong; Yunsop Chong
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.